The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Enforcement In 2025: What The Data Reveals So Far fda warning bpc 157 peptide products New Details 157 Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida